Legal Representation
Attorney
Michele K. Robichaux
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 11, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 11, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Nov 11, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 11, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 11, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 5, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 5, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| May 5, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| May 5, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 24, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 24, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Feb 24, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Nov 12, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 17, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 17, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 28, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 12, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 12, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 7, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Feb 6, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 20, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and therapeutic pharmaceuticals for use in oncology, immunology, cardiology, endocrinology, diabetology, pain management, neurology, hematology, dermatology, and critical care; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and therapeutic pharmaceuticals for the prevention and treatment of cancer and cancer-related comorbidities; pharmaceuticals used for stimulating white blood cell production; Pharmaceutical preparations for the treatment of bone diseases, infectious diseases, liver disease, obesity, kidney disease, mental health conditions, Alzheimer's disease, respiratory diseases and disorders, skin disorders, asthma, inflammatory diseases, auto-immune and immune-based disorders, cardiovascular disorders, neurological diseases and disorders, auto-immune and immune-based diseases, and critical illness; Pharmaceutical preparations, namely, anti-diabetics, cardiovascular agents, anti-rheumatics, vaccines, anti-viral medications, immunosuppressants, bronchodilators, anti-coagulants, anti-histamines, anti-inflammatory and anti-arthritic preparations
Class 044
Medical services, namely, providing medical and health information to patients in the areas of oncology, immunology, cardiology, endocrinology, diabetology, pain management, neurology, hematology, dermatology, and critical care
Additional Information
Design Mark
The mark consists of a positive-space hexagon with a hexagon-shaped negative space in the center where the positive-space hexagon is divided in half by the negative-space hexagon and two negative-space lines, one negative-space line radiating in a downward curve to the left from the upper left corner of the negative-space hexagon to the outside of the middle left corner of the positive-space hexagon, and one negative-space line radiating in an upward curve to the right from the lower right corner of the negative-space hexagon to the outside of the middle right corner of the positive-space hexagon.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
044